CANY
CRVS icon

Caxton Associates (New York)’s Corvus Pharmaceuticals CRVS Stock Holding History

Caxton Associates (New York)’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,325
Closed -$104K – 515
2021
Q4 		$104K Buy
+43,325
New +$104K 0.01% 499